In vivo reduction of medium- to long-chain fatty acids by carboxylic acid reductase (CAR) enzymes: limitations and solutions

Melissa Horvat, Margit Winkler*

*Corresponding author for this work

Research output: Contribution to journalArticle

Abstract

Fatty aldehyde production by chemical synthesis causes an immense burden to the environment. Within in this study, we explored a sustainable, aldehyde‐selective and mild alternative approach by utilizing carboxylic acid reductases (CARs). CARs from Neurospora crassa ( Nc CAR), Thermothelomyces thermophila ( Tt CAR), Nocardia iowensis ( Ni CAR), Mycobacterium marinum ( MmC AR) and Trametes versicolor ( Tv CAR) were overexpressed in E. coli K‐12 MG1655 RARE (DE3) and screened for medium‐ to long‐chain fatty acid (C6‐C18) reduction. MmC AR showed the broadest tolerance towards all carbon‐chain lengths and was selected for further investigations of fatty aldehyde synthesis in whole cells. To yield relevant product concentrations, different limitations of CAR whole cell conversions were elucidated and compensated. We coupled an in vitro cofactor recycling system to a whole cell biocatalyst to support cofactor supply and achieved 12.36 g L ‐ 1 of octanal (STY 0.458 g L ‐1 h ‐1 ) with less than 1.5 % of 1‐octanol.
Original languageEnglish
Number of pages16
JournalChemCatChem
DOIs
Publication statusAccepted/In press - 7 Jul 2020

Fields of Expertise

  • Human- & Biotechnology

Fingerprint Dive into the research topics of 'In vivo reduction of medium- to long-chain fatty acids by carboxylic acid reductase (CAR) enzymes: limitations and solutions'. Together they form a unique fingerprint.

  • Cite this